About Agentase
Agentase is a Healthcare company based in Pittsburgh (United States) founded in 1998, and was acquired by FLIR Systems in August 2010. Applications and products that detect chemical and biological agents. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Kits and Reagents. Its competitors include GenScript, OriGene and Meridian Bioscience; 2 of its 3 listed competitors have raised funding.
Company details
Agentase engages in the development and implementation of biocatalysts in a range of applications. It offers Chemical Agent Detection Kit, a system that detects low levels of chemical warfare agents; Hospital Readiness Kit that detects the presence of harmful chemical agents before they contaminate the hospital; and Training Sensor Kit, which simulates the usage of agentase CAD kit sensors for detection of chemical warfare agents with these hands-on training kits. Agentase operates as a subsidiary of FLIR Systems
- Headquarters Pittsburgh, United States
- Stage Acquired
- SectorsHealthcare
- Website agentase.com
- Acquired by FLIR Systems (Aug 2010)
- Latest Funding Round$7.9M (USD), Grant
Jan 2013
- InvestorsFLIR
& 3 more
- Acquired byFLIR Systems
(Aug 2010)
Funding Insights of Agentase
- Total Rounds 3
- Last Round Grant — $7.9M
- First Round $100,000
(Apr 2004)
- Investors Count 3
All 3 funding rounds of Agentase with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2013 | $7.9M | Grant | – | – | |
| Apr 2007 | $960,000 | Grant | – | – | |
| Apr 2004 | $100,000 | Unspecified | – | – |
4 investors in total: 4 institutional.
Investors in Agentase
Agentase has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include FLIR, U.S Army and DARPA.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Support is offered for life sciences startups in Pittsburgh. | 2002 | plsg.com | Pittsburgh, United States | |
| 1958 | darpa.mil | United States | ||
Land-based military forces are organized and deployed for national defense. | 1775 | army.mil | ||
Thermal imaging solutions are provided by FLIR for various industries. | 1978 | flir.com | Wilsonville, United States |
Investor details for Agentase
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Agentase
4 dated milestones of Agentase across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Agentase is founded.
- Funding First funding round of $100K.
- Exit Acquired by FLIR Systems.
- Funding Latest funding round, Grant, of $7.9M.
Competitors of Agentase
Agentase has 3 listed competitors in our database, 2 of them funded. They include GenScript, OriGene and Meridian Bioscience.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| origene.com | 1996 | Rockville, United States | $69.55M | 141 | Proteins, antibodies, and molecular tools are manufactured for research applications. | |
| meridianbioscience.com | 1976 | Ohio, United States | Molecular diagnostic device and kits |
Detailed competitors of Agentase
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Agentase (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Agentase
Agentase was founded in 1998 and raised its 1st funding round 6 years after it was founded.
Agentase is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.
Agentase engages in the development and implementation of biocatalysts in a range of applications. It offers Chemical Agent Detection Kit, a system that detects low levels of chemical warfare agents; Hospital Readiness Kit that detects the presence of harmful chemical agents before they contaminate the hospital; and Training Sensor Kit, which simulates the usage of agentase CAD kit sensors for detection of chemical warfare agents with these hands-on training kits. Agentase operates as a subsidiary of FLIR Systems.
Agentase's top competitors include Meridian Bioscience, GenScript and OriGene.
Agentase has 4 investors. Key investors include FLIR, U.S Army, DARPA, and Pittsburgh Life Sciences Greenhouse.
Yes. Agentase was acquired by FLIR Systems in August 2010.